Fast Five Quiz: Rheumatoid Arthritis Interstitial Lung Disease Management

Zab Mosenifar, MD


April 05, 2021

Pulmonary manifestations of connective-tissue disease (CTD) may arise before, during, or years after the onset of articular disease. Interstitial lung disease (ILD) is the most common pulmonary manifestation of rheumatoid arthritis (RA) and may develop as a result of chronic immune activation and inflammation with subsequent aberrant fibroproliferation. It may also be rooted in drug-related or infectious causes. Although there is a paucity of robust evidence to support current recommendations, management of RA-ILD comprises both supportive measures and treatment against the inflammatory processes responsible for its pathogenesis. Although the American College of Rheumatology recommendations do not specifically address the co-occurrence of RA and ILD, consensus does suggest that extra-articular disease carries a less favorable prognosis and therefore should receive more aggressive treatment.

How much do you know about managing ILD in the context of RA? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.